Clinical Study
Medication Responsiveness of Motor Symptoms in a Population-Based Study of Parkinson Disease
| Medication status | (%) | Daily dosage (mg) mean (SD) |
| Levodopa only | 67 (34.9) | | Carbidopa/levodopa | 43 (22.3) | 513.9 (254.6) | Carbidopa/levodopa (Sinemet CR or XR) | 18 (9.3) | 500.0 (205.8) | Levodopa and any other medication | 108 (56.3) | | Pramipexole | 46 (23.8) | 2.3 (1.7) | Ropinirole | 33 (17.1) | 7.3 (6.9) | Bromocryptine | 2 (1.0) | 2.5 (0.0) | Carbidopa/levodopa | 80 (41.5) | 557.6 (307.2) | Carbidopa/levodopa (Sinemet CR or XR) | 37 (19.2) | 585.1 (296.9) | Amantadine | 11 (5.7) | 227.3 (46.7) | Trihexyphenidyl | 4 (2.1) | 5.5 (3.4) | Entacapone | 23 (11.9) | 747.8 (219.2) | Dopamine agonists without levodopa | 17 (8.9) | | Pramipexole | 10 (5.2) | 2.4 (1.4) | Ropinirole | 7 (3.6) | 8.6 (4.7) |
|
|